Atom | Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers

Due Dates: September 15, 2026: Full application submission deadline (single-stage) — 17:00 Brussels time

Funding Amounts: €7–8 million per project; total budget €22,186,000; ~3 grants expected

Summary: Supports pragmatic clinical trials to optimise, tailor, and make immunotherapy more accessible and effective for patients with refractory cancers across Europe.

Key Information: Single-stage, lump sum funding; requires multidisciplinary, multi-country collaboration and patient engagement.

Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers

Sign in to see full grant listing